Market revenue in 2023 | USD 108.0 million |
Market revenue in 2030 | USD 154.8 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Inactivated (killed) |
Fastest growing segment | Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
Key market players worldwide | Merck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 38.43% in 2023. Horizon Databook has segmented the Latin America swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.
The market for swine vaccines in Latin America is anticipated to grow during the forecast period due to various factors such as rise in the demand for swine protein and increase in consumer interest in high protein & low-fat diets, which has led to a significant increase in the consumption of animal protein, including pork, in the region.
Brazil, Mexico, and Argentina are all part of the Latin American region. Moreover, supportive business initiatives, such as conducting porcine circovirus programs, in Brazil, are expected to fuel the growth of swine vaccines market in Latin America.
For instance, in June 2022, Virbac conducted an IPVS, a significant gathering for swine industry professionals looking for the most recent scientific information on porcine circovirus and a preventive approach to swine health that emphasizes modern technologies and immunization techniques.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America swine vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account